8 suspended. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Suspended 8 |
| Phase 1 | 1 | Suspended 1 |
Follow Leukemia, Lymphoid: new trials by email Literature Review of Leukemia, Lymphoid trials Research Report on Leukemia, Lymphoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pyronaridine in Acute Myeloid Leukemia (AML) Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Suspended | Armaceutica, Inc. | 200 | 2028-02-21 | 2026-10-19 |
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Collection - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia | Phase 2 | Suspended | University of Washington | 30 | 2026-05-08 | 2026-09-29 |
| Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia Blinatumomab - Phase 2 Study, Blinatumomab | Phase 2 | Suspended | M.D. Anderson Cancer Center | 40 | 2026-04-21 | 2026-10-08 |
| ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis Cyclophosphamide, Fludarabine, Thiotepa - Acute Myelogenous Leukemia, Acute Lymphatic Leukemia | Phase 2 | Suspended | Leland Metheny | 20 | 2026-04-08 | 2026-09-10 |
| A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma Brincidofovir - Relapsed or Refractory Lymphoma Including ENKL | Phase 1 / Phase 2 | Suspended | SymBio Pharmaceuticals | 43 | 2025-06-09 | 2026-02-05 |
| Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients Oshadi D & Oshadi R;, salvage therapy cytosar and mitoxantrone - Acute Myeloid Leukemia, Lymphoid Leukemia | Phase 2 | Suspended | Oshadi Drug Administration | 15 | 2017-01-01 | 2018-04-18 |
| Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia Alemtuzumab - B-cell Chronic Lymphocytic Leukemia | Phase 2 | Suspended | Shanghai Zhangjiang Biotechnology Limited Company | 120 | 2011-07-01 | 2022-06-21 |
| Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) Imatinib Mesylate - Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) | Phase 2 | Suspended | Renato Melaragno | 20 | 2013-03-26 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Leukemia, Myeloid, Acute (3) · Lymphoma (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Burkitt Lymphoma (1) · Epstein-Barr Virus Infections (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1)
Hematologic Diseases (8) · Hemic and Lymphatic Diseases (8) · Immune System Diseases (8) · Immunoproliferative Disorders (8) · Lymphatic Diseases (8) · Lymphoproliferative Disorders (8) · Neoplasms by Histologic Type (8) · Leukemia (7) · Neoplasms (7) · Disease Attributes (3) · Leukemia, Myeloid (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2)
Cyclophosphamide (2) · Abatacept (1) · Alemtuzumab (1) · Antineoplastic Agents (1) · Asparaginase (1) · CT-P10 (1) · Doxorubicin (1) · Etoposide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Imatinib Mesylate (1) · Magnetic Resonance Spectroscopy (1) · Mitoxantrone (1) · Mycophenolic Acid (1) · Prednisone (1)
Armaceutica, Inc. (1) · Leland Metheny (1) · M.D. Anderson Cancer Center (1) · Oshadi Drug Administration (1) · Renato Melaragno (1) · Shanghai Zhangjiang Biotechnology Limited Company (1) · SymBio Pharmaceuticals (1) · University of Washington (1)
United States (3) · China (2) · Japan (1) · Senegal (1) · Singapore (1)
Elias Jabbour, MD (1) · Jun Zhu, M.D. (1) · Leland Metheny, MD (1) · Moshe Gatt, MD (1) · Renato J Aguilera, PhD (1) · Ryan D. Cassaday, MD (1)